3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
8
Gynecologic
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
43
Pain, Postoperative
6
Motor Activity
4
Pain
3
Fatigue
3
Agnosia
3
Sleep Initiation and Maintenance Disorders
2
Parasomnias
2
Hot Flashes
2
Depression
2
Chronic Pain
2
Breast Cancer Female
2
Weight Loss
1
Syndrome
1
Peripheral Nervous System Diseases
1
Patient Participation
1
Ovarian Neoplasms
1
Neoplasms
1
Lymphedema
1
Lung Neoplasms
1
Health Education
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Breast Self-Examination
1
Breast Cancer Survivors
1
Body Weight Changes
1
Anxiety Disorders
1
Alzheimer Disease
1
Altitude Sickness
1
Acute Pain
1
Interventions
Paclitaxel
26
pembrolizumab
24
Docetaxel
20
Capecitabine
19
Fulvestrant
17
Trastuzumab
16
Anastrozole
15
Cyclophosphamide
14
Lapatinib
13
Letrozole
11
Carboplatin
11
Radiotherapy
10
Doxorubicin
10
palbociclib
9
Therapeutics
9
Nivolumab
9
Exercise
9
Gemcitabine
8
Cisplatin
8
Blood Specimen Collection
8
Tamoxifen
7
Bevacizumab
7
liposomal doxorubicin
6
exemestane
6
abemaciclib
6
Vinorelbine
6
Standard of Care
6
Fluorouracil
6
atezolizumab
5
Surveys and Questionnaires
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Control Groups
×
Breast
×
Clear all
NCT04877860
2023-05-09
PaiNEd
Universidad de Granada
Phase NA
Unknown
72 enrolled